Tecfidera (BG-12) Nrf2 Activator Approved by FDA for Multiple Sclerosis (MS) Treatment

Although there is no treatment that will cure Multiple Sclerosis, there are three oral medications approved by the FDA to be a first-line treatment to slow down the progression of the disease. Dimethyl Fumarate (Tecfidera, Biogen Idec)  joins fingolimod (Gilenya) and teriflunomide (Aubagio) as the new “kid on the block”. It is specifically approved for… Continue reading Tecfidera (BG-12) Nrf2 Activator Approved by FDA for Multiple Sclerosis (MS) Treatment